JANE STREET GROUP, LLC - BRIDGEBIO PHARMA INC ownership

BRIDGEBIO PHARMA INC's ticker is and the CUSIP is 10806X902. A total of 4 filers reported holding BRIDGEBIO PHARMA INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
JANE STREET GROUP, LLC ownership history of BRIDGEBIO PHARMA INC
ValueSharesWeighting
Q2 2024$47,496,283
+373.7%
1,875,100
+478.2%
0.01%
+450.0%
Q1 2024$10,027,356
-51.2%
324,300
-36.2%
0.00%
-60.0%
Q4 2023$20,532,182
+72.9%
508,600
+13.0%
0.01%
+25.0%
Q3 2023$11,871,774
+31.5%
450,200
-14.2%
0.00%
+33.3%
Q2 2023$9,026,560
+72.7%
524,800
+66.5%
0.00%
+50.0%
Q1 2023$5,226,016
+3819.0%
315,200
+1701.1%
0.00%
Q4 2022$133,350
-85.0%
17,500
-80.4%
0.00%
Q3 2022$887,000
-40.3%
89,200
-45.5%
0.00%
-100.0%
Q2 2022$1,487,000163,8000.00%
Other shareholders
BRIDGEBIO PHARMA INC shareholders Q2 2022
NameSharesValueWeighting ↓
GROUP ONE TRADING, L.P. 99,800$906,0000.00%
SIMPLEX TRADING, LLC 89,700$814,0000.00%
JANE STREET GROUP, LLC 163,800$1,487,0000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
View complete list of BRIDGEBIO PHARMA INC shareholders